Linda M. Pilarski

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

Genetics and Cytogenetics of Multiple Myeloma

Rafaël Fonseca, Bart Barlogie, Régis Bataille et al. · Cancer Research · 2004 · 686 citations

Medicine, Genetics, Molecular Genetics +17

In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression

Jonathan J. Keats, Tony Reiman, Christopher A. Maxwell et al. · Blood · 2003 · 384 citations

Medicine, Hematology, Oncology +7

In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.

D E Lopes de Menezes, Linda M. Pilarski, Theresa M. Allen · PubMed · 1998 · 260 citations

Pharmacy, Oncology, Pharmacology +17

RHAMM Is a Centrosomal Protein That Interacts with Dynein and Maintains Spindle Pole Stability

Christopher A. Maxwell, Jonathan J. Keats, Mary Crainie et al. · Molecular Biology of the Cell · 2003 · 194 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17